Weill Medical College Of Cornell University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1865-01-01

Employees: -

Market Cap: -

Website: http://weill.cornell.edu

Clinical Trials

A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery

Not Applicable

Recruiting

Conditions: Mammaplasty
Mastectomy
Breast Reconstruction

Interventions: Device: REVOLVE Advanced Adipose System
Procedure: Viality
Device: LipoGrafter

First Posted Date: 2021-05-18

Last Posted Date: 2024-05-22

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 90

Registration Number: NCT04891510

Locations: 🇺🇸
New York Presbyterian - Weill Cornell Medicine, New York, New York, United States

Prostate Cancer - Comparative Outcomes of New Conceptual Paradigms for Treatment

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Other: Patient-reported questionnaire

First Posted Date: 2021-05-18

Last Posted Date: 2024-05-17

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 2629

Registration Number: NCT04890314

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States
🇺🇸
New York State Department of Health, Albany, New York, United States
🇺🇸
University of Kansas, Kansas City, Kansas, United States

and more 1 locations

Piloting Virtual Reality Environments to Treat PTSD in Healthcare Workers

Early Phase 1

Recruiting

Conditions: Posttraumatic Stress Disorder

Interventions: Behavioral: Virtual Reality Exposure Therapy

First Posted Date: 2021-05-14

Last Posted Date: 2024-11-26

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 20

Registration Number: NCT04887116

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Phase I/II 225Ac-J591 Plus 177Lu-PSMA-I&T for Progressive Metastatic Castration Resistant Prostate Cancer

Phase 1

Suspended

Conditions: Prostate Cancer

Interventions: Drug: 225Ac-J591
Drug: 177Lu-PSMA-I&T
Drug: 68Ga-PSMA-11

First Posted Date: 2021-05-14

Last Posted Date: 2024-07-30

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 48

Registration Number: NCT04886986

Locations: 🇺🇸
Brooklyn Methodist Hospital - New York Presbyterian, Brooklyn, New York, United States
🇺🇸
Weill Cornell Medicine New York Presbyterian, New York, New York, United States

Positive Affect as a Source of Resilience for Adults in Chronic Pain

Not Applicable

Completed

Conditions: Chronic Pain
Geriatric

Interventions: Behavioral: LARKSPUR

First Posted Date: 2021-05-03

Last Posted Date: 2023-05-01

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 95

Registration Number: NCT04869345

Locations: 🇺🇸
NewYork-Presbyterian - Weill Cornell Medicine, New York, New York, United States

Tissue Collection for Drug Screening and Bioanalysis

Recruiting

Conditions: Central Nervous System Tumor

First Posted Date: 2021-04-21

Last Posted Date: 2024-07-31

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 500

Registration Number: NCT04852354

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Improving Cognitive Health in COVID-19 Survivors

Phase 2

Completed

Conditions: Covid19
Cognitive Dysfunction

Interventions: Device: AKL-T01

First Posted Date: 2021-04-14

Last Posted Date: 2024-02-29

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 110

Registration Number: NCT04843930

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy

Not Applicable

Completed

Conditions: Infection

Interventions: Procedure: Transrectal MRI-guided prostate biopsy
Procedure: Transperineal MRI-guided prostate biopsy
Drug: Antibiotic (prophylaxis)

First Posted Date: 2021-04-13

Last Posted Date: 2024-05-31

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 738

Registration Number: NCT04843566

Locations: 🇺🇸
University of Connecticut, Farmington, Connecticut, United States
🇺🇸
University of Michigan Medical School, Ann Arbor, Michigan, United States
🇺🇸
Georgetown University, Washington, District of Columbia, United States

and more 7 locations

Treatment of Selinexor in Combination With Clarithromycin, Pomalidomide and Dexamethasone for Relapsed Refractory Multiple Myeloma Patients

Phase 2

Terminated

Conditions: Myeloma
Myeloma Multiple
Refractory Multiple Myeloma

Interventions: Drug: Selinexor
Drug: Clarithromycin
Drug: Pomalidomide
Drug: Dexamethasone

First Posted Date: 2021-04-13

Last Posted Date: 2023-10-25

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 4

Registration Number: NCT04843579

Locations: 🇺🇸
Weill Cornell Medicine - Multiple Myeloma Center, New York, New York, United States
🇺🇸
NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York, United States

PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy 2

Not Applicable

Recruiting

Conditions: Infection

Interventions: Procedure: Transperineal MRI-guided prostate biopsy
Procedure: Transrectal MRI-guided prostate biopsy
Drug: Antibiotic (prophylaxis)

First Posted Date: 2021-03-25

Last Posted Date: 2024-04-12

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 1302

Registration Number: NCT04815876

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
University of Southern California, Los Angeles, California, United States

and more 13 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy